Chronic kidney disease is a common condition, but many people who are living with it don't know that they have it.People in the Black Community are at a higher risk of developing APOL-1 mediate kidney disease.
If you have chronic kidney disease or kidney problems run in your family and are of African descent, you may be able to participate in a clinical research study for APOL1-mediated kidney disease.
Register Your Interest for Our Upcoming Asthma Study
We're preparing for an exciting new asthma study, and we would love for you to join! If you or someone you know has asthma, this is a great opportunity to stay informed about potential new treatments.
Why Register?
Be the first to know when the study starts
Receive information about participation opportunities
Help researchers learn more about asthma treatments
Who Can Join?
We're looking for individuals with asthma. If you are interested, simply register your details, and we will keep you updated!
Depression Research Study (Major Depressive Disorder)
Are you 18 to 65 years old?
Do you have Major Depressive Disorder (MDD)?
Have you experienced an inadequate response to your current antidepressant (SSRI or SNRI)?
A clinical research study is now enrolling adults diagnosed with MDD to evaluate whether an investigational medication, taken alongside a standard antidepressant, may improve symptoms of depression.
Participants will continue taking their existing antidepressant and receive either the study medication or a placebo (contains no active ingredients).Those who qualify may receive:
Study medication or placebo in addition to your current treatment
Care and monitoring from a dedicated study team
Reimbursement for time, travel, and study-related expenses
A chance to contribute to the future of mental health research
A clinical research study is now enrolling adults diagnosed with MDD to evaluate whether an investigational medication, taken alongside a standard antidepressant, may improve symptoms of depression.
Participants will continue taking their existing antidepressant and receive either the study medication or a placebo (contains no active ingredients). Those who qualify may receive:
Study medication or placebo in addition to your current treatment
Care and monitoring from a dedicated study team
Reimbursement for time, travel, and study-related expenses
A chance to contribute to the future of mental health research
Study for Adults with Obesity or Excess Weight (Overweight)
For participants who are 18 to 75 years old and have a BMI greater than 30 or a BMI greater than 27 with at least one of the following conditions: high blood pressure, high cholesterol, heart disease, or obstructive sleep apnea. Eligible participants should not have had any significant weight changes in the past three months, should not have taken weight loss medications during this period, and should not have undergone or be planning to undergo bariatric surgery or the fitting of a weight loss device. Additionally, individuals with diabetes are not eligible. Participants must also be willing to use approved forms of contraception during the study. Further criteria will be assessed to confirm eligibility.
The study is investigating an investigational drug designed to mimic the effects of amylin, a hormone that signals fullness, delays gastric emptying, and lowers blood sugar levels. By working like amylin, the drug aims to help reduce food intake and promote weight loss. Participants in the study will receive a weekly injection of either the study drug or a placebo for up to 36 weeks (approximately eight months). If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
